No single ticker was named. Biotech ETFs are one way for retail investors to get exposure. Not a recommendation.
FDA reform needed for US drug development competitiveness
Excessive FDA regulation threatens US drug development, risking market share loss to China and other regions unless early-stage safety protocols and technology adoption are modernized.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.